** Shares of telehealth company Mangoceuticals MGRX.O ,
also known as MangoRx, rise as much as 9.8% to an over
five-month high of $6.15; last up 4.9% in morning trade
** Co says it is launching a women's telehealth brand called
PeachesRx, to focus on personalized wellness and GLP-1 weight
loss treatments
** GLP-1 receptor agonists is a class of medication proven
to aid weight loss by regulating appetite and glucose metabolism
** Co aims to offer access by providing affordable and
medically supervised treatments via its telemedicine platform
** In the last 12 months, MGRX has risen ~31%
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))